Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib roll-over study for patients benefiting after prior Novartis nilotinib trials
NL-OMON50344Phase 4Active, not recruiting
- Sponsor
- Novartis
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nilotinib, sponsored by Novartis. Started May 2013; status: active, not recruiting.
02
Drugs
nilotinib
Beyond the preview
Go deeper on NL-OMON50344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50344.